The challenge of experimentally characterizing transporters is formidable. Membrane proteins are notoriously unstable once removed from their native lipid environment, which complicates purification, crystallization, and nearly every classical biochemical assay used to establish what a protein binds. As a result, curated databases of experimentally verified transporter–substrate relationships cover only a small fraction of known transporters, and many solute carrier proteins—the largest transporter family in humans—remain so-called orphans with no assigned substrate. Computational tools could in principle fill this gap, but existing methods have tended to focus on narrow classes of substrates or have struggled to generalize to transporters that are evolutionarily distant from those in their training data.

TraSPIN, developed by Tong Pan, Fuyi Li, Jiangning Song, and colleagues at institutions including the South Australian immunoGENomics Cancer Institute, Monash University, and the University of Melbourne, takes a fundamentally different approach. The framework is built on geometric deep learning, a branch of machine learning designed to operate on graph-structured data, and it jointly models both sides of the recognition problem: the transporter protein and the small-molecule substrate. By representing transporters and substrates in a shared learning framework, the model can learn the relational patterns that connect a protein’s sequence and structure to the chemical features of the molecules it accepts.

A central innovation is the use of protein language models as the foundation for transporter representations. These models, analogous to the large language models behind modern chatbots, are trained on enormous databases of protein sequences and learn to encode the statistical grammar of amino acid chains. In doing so, they capture subtle information about which positions in a sequence are functionally constrained, which residues are likely to form binding pockets, and how mutations are tolerated. TraSPIN leverages these learned embeddings to build rich, transferable representations of transporters, which are then combined with graph-based learning over protein–substrate interaction networks. The graph structure allows the model to propagate information across related transporters and related substrates, so that knowledge about one interaction informs predictions about others.

This architecture matters because specificity prediction is, at its core, a link-prediction problem on a sparse and biased network. The known interaction map is dense only for a handful of well-studied transporter families and substrate classes, such as sugar transporters or neurotransmitter carriers. A model that simply memorizes these dense regions performs poorly when asked about a transporter from an unexplored family. TraSPIN’s language-model-guided design is explicitly aimed at this generalization problem. In benchmark comparisons reported in the paper, the framework outperformed existing computational methods, and critically, it retained predictive accuracy on substrates it had never seen during training and on transporters whose sequences are dissimilar to anything in the training set—precisely the scenarios where earlier tools broke down.

Beyond raw prediction accuracy, the authors show that TraSPIN is interpretable in biologically meaningful ways. The model’s internal representations can be interrogated to reveal structural determinants of transporter–substrate recognition and sequence motifs associated with binding particular classes of molecules. In other words, the network does not behave as an inscrutable black box; it appears to have learned features that map onto real biochemical principles of molecular recognition. This kind of mechanistic insight is valuable in its own right, because it can guide experimentalists toward specific residues or structural regions to mutate and test, turning a purely computational prediction into a testable hypothesis.

The practical demonstrations in the study highlight two applications with immediate relevance to biology and medicine. The first is cross-species inference: using knowledge accumulated about transporters in well-characterized organisms to predict substrate specificities in species where little experimental data exists. This matters for microbiology, parasitology, and biotechnology, where transporter function in non-model organisms often underpins nutrient uptake, drug resistance, and metabolic engineering. The second application is de-orphanization—the assignment of substrates to uncharacterized solute carrier proteins. Human solute carriers regulate drug absorption, metabolism, and disposition, and orphan carriers are increasingly recognized as potential therapeutic targets and as mediators of unexplained drug–drug interactions. A reliable computational tool that can propose substrates for these orphans could dramatically accelerate functional annotation efforts that would otherwise require years of laboratory work.

The broader context is a rapidly growing intersection between artificial intelligence and structural biology. Protein language models have already transformed fields from structure prediction to protein design, and geometric deep learning has proven adept at tasks where the geometry of molecules—whether the three-dimensional fold of a protein or the two-dimensional scaffold of a small molecule—carries the essential signal. TraSPIN sits squarely at this confluence, treating transporter specificity not as an isolated classification task but as a relational inference problem across a heterogeneous graph of proteins and chemicals. The authors’ results suggest that this joint modeling strategy, rather than modeling proteins and substrates separately, is key to the framework’s generalization ability.

There are, of course, the usual caveats that accompany any machine learning advance in biology. Predictions of transporter–substrate interactions are hypotheses, not measurements, and the sparsity of ground-truth data means that performance estimates on rare substrate classes carry uncertainty. The authors acknowledge that experimental validation remains essential, and the model’s greatest value may lie in prioritizing which of thousands of untested transporter–substrate pairs should be examined first in the laboratory. Used this way—as an intelligent filter rather than an oracle—computational frameworks like TraSPIN can multiply the productivity of experimental programs focused on membrane proteins, where each assay is technically demanding and expensive.

Nevertheless, the arrival of TraSPIN marks a significant step toward solving one of the most persistent annotation problems in molecular biology. The genomes of humans and of every model organism encode hundreds of transporters whose substrates have never been determined, and each uncharacterized carrier is a potential link in a metabolic pathway, a drug target, or a determinant of drug response. By combining the sequence-reading power of protein language models with the relational reasoning of graph learning, TraSPIN offers a scalable route from sequence to function for this protein universe. If its predictions continue to hold up under experimental scrutiny, the era in which transporter specificity is inferred by computer before it is confirmed at the bench may arrive sooner than anyone expected.

Subject of Research: Computational prediction of membrane transporter substrate specificity using protein language models and geometric deep learning

Article Title: TraSPIN: inferring transporter specificity through language model-guided graph learning

Article References: Pan, T., Liu, J., Xu, J., Han, R., Ran, Z., Guo, X., Hao, Y., Bi, Y., Li, F., & Song, J. (2026). TraSPIN: inferring transporter specificity through language model-guided graph learning. Genome Biology. https://doi.org/10.1186/s13059-026-04309-2

Image Credits: AI Generated

DOI: 10.1186/s13059-026-04309-2

Keywords: membrane transporters, substrate specificity, TraSPIN, protein language models, geometric deep learning, graph learning, solute carriers, de-orphanization, protein-substrate interactions, functional annotation, Genome Biology, machine learning

The system is called GRETA, short for Genetic REsults daTAbase, and it was developed by Cristian Riccio, Amra Dhabalia Ashok, Georgios Koliopanos and Andreas Ziegler at Cardio-CARE in Davos, together with colleagues at the University Medical Center Hamburg-Eppendorf, the University of Lübeck and the University of KwaZulu-Natal. At its core, GRETA is a relational database, meaning that information is organised into structured tables connected by defined keys, so that any single association result can be linked back to the exact dataset, analysis pipeline and parameter settings that produced it. That traceability is not a luxury. In genetic epidemiology, where a single spurious association can send a research group down a months-long dead end, knowing precisely how a result was generated is as important as the result itself.

What makes GRETA unusual is not merely that it stores data, but how it was designed. Rather than asking software engineers to guess what geneticists need, the team ran a formal requirements-engineering process grounded in user-centred design, a methodology borrowed from human-computer interaction in which the intended users shape the product at every stage. Through this process they defined product specifications across eight categories, covering everything from data upload and a graphical user interface to identity and access management and data protection. Only after these requirements were fixed did the team evaluate commercial database solutions and select a vendor to implement them, a deliberate choice to build on proven infrastructure rather than reinventing database technology from scratch.

The technical architecture reflects the realities of modern genomics. GRETA is built as a relational database management system, using Structured Query Language under the hood, but most users will never write a query. Instead, they interact with the system through a graphical user interface that allows interactive querying and visualisation of association results. Behind the scenes, the relational schema connects in-house association results, whether from genome-wide association studies or rare variant association studies, with public reference resources such as the Genotype-Tissue Expression project and functional annotation tools like Functional Mapping and Annotation. Every result carries links to its underlying data and analysis parameters, so a researcher can trace a finding from a summary statistic all the way back to the cohort and pipeline that produced it.

This matters because the people who most need access to genetic association results are often not the people who can get it. Traditionally, interrogating large result sets required command-line skills, familiarity with database systems and comfort manipulating enormous text files on high-performance computing clusters. Clinicians, early-career scientists and collaborators in adjacent fields were frequently locked out of the full richness of their own projects’ data. GRETA was explicitly designed to close that gap: the platform makes large-scale association results accessible to researchers without programming skills, while retaining the depth and flexibility that computational specialists expect. The result, the authors argue, is a secure, multi-user solution for exploring genetic association results and their functional annotation at scale.

The development team did not work in the abstract. GRETA was built to serve real studies, including the Hamburg City Health Study, one of Germany’s large population-based cohorts, whose participants and study staff made the underlying dataset possible. The genetic association analysis pipeline feeding the database was developed with contributions from researchers at Cardio-CARE, and the database itself was built by Mark Mallabone of Ovations Technologies Ltd, with the graphical interface implemented by Peter Wanjohi and Wisaal Behardien of iOCO GmbH. The collaboration between academic geneticists, statisticians and commercial software developers is itself a notable feature of the project, reflecting a growing recognition that scientific data infrastructure is too important and too complex to be left to ad hoc scripting.

Data protection received particular attention, and for good reason. Genomic data is among the most sensitive categories of personal information that exist, and studies like the Hamburg City Health Study operate under strict ethical oversight. The ethics committee of the Hamburg Medical Association raised no objections to the conduct of the study, and approvals were obtained from the data protection officer of the University Medical Center Hamburg-Eppendorf and the data protection commissioner of the Free and Hanseatic City of Hamburg. GRETA’s identity and access management features are designed to ensure that only authorised users can reach the results they are entitled to see, a crucial requirement for any platform intended to serve multiple research groups handling human genomic data.

Perhaps the most consequential decision the team made was to publish everything. Alongside the paper, the researchers have released the product requirements, the relational schema and the complete list of functionalities, so that other institutions can reproduce the system elsewhere. In a field where data infrastructure is often proprietary, fragmented or poorly documented, this commitment to openness could prove as influential as the software itself. The article is published open access under a Creative Commons licence, and extensive supplementary materials accompany it, giving any laboratory or consortium a detailed blueprint for building its own results database tailored to its own studies.

The implications reach well beyond cardiology, the field in which GRETA was born. As whole-genome sequencing becomes cheaper and cohort studies grow larger, the bottleneck in genetic research is shifting from data generation to data management and interpretation. Rare variant association studies, in particular, produce enormous volumes of results across vast numbers of genes, and integrating them with tissue-specific expression data and functional annotations is exactly the kind of task that overwhelms spreadsheets and home-grown scripts. A well-designed relational database that unifies results and reference data in one queryable place could accelerate everything from gene discovery to the interpretation of a patient’s genome in a clinical setting.

There are, of course, caveats. GRETA is a tool for storing and exploring association results, not a substitute for rigorous statistical analysis or biological validation, and its value depends on the quality of the results fed into it. The published paper describes an early-release version subject to further editorial revision, and the true test of any database is adoption by research groups beyond its birthplace. But the problem it addresses is real, widespread and growing, and the authors’ decision to share the full design openly means that the barrier to trying it elsewhere is unusually low. If GRETA and systems like it become standard fixtures in genomics laboratories, the era in which billions of hard-won genetic associations languished in unread files may finally be drawing to a close.

Subject of Research: A relational database for storing, integrating and querying whole-genome sequencing association results with public reference data

Article Title: GRETA: a results database for whole-genome sequencing studies

Article References: Riccio, C., Ashok, A. D., Guo, L., Koliopanos, G., Zeller, T., Twerenbold, R., & Ziegler, A. (2026). GRETA: a results database for whole-genome sequencing studies. BMC Bioinformatics. https://doi.org/10.1186/s12859-026-06688-6

Image Credits: AI Generated

DOI: 10.1186/s12859-026-06688-6

Keywords: GRETA, whole-genome sequencing, relational database, genome-wide association study, rare variant association study, user-centred design, bioinformatics, genetic association results, functional annotation, data protection, cardiogenomics, Hamburg City Health Study

The problem Genolator addresses is one of the most stubborn bottlenecks in modern biology. Sequencing a genome has become fast and cheap, but interpreting it has not. Vast stretches of the human genome remain functionally unexplored, and even for the genes we do know, assigning a protein to a role—where it operates inside the cell, which molecular tasks it performs, and which biological processes it participates in—still relies heavily on laborious experimental work and expert curation. The Gene Ontology framework, the standard vocabulary researchers use to describe protein functions, has grown enormous precisely because this annotation task is so demanding. Every uncharacterized protein is a potential blind spot in our understanding of disease mechanisms and, by extension, in the development of targeted treatments.

Large language models have transformed how machines handle human text, but genomic data has stubbornly resisted the same revolution. The reason, the Aachen team argues in the study, is that existing models are divided into two camps that rarely speak to each other. Some language models can process natural language; others can process genomic code; models that genuinely fuse both modalities have been largely lacking. Genolator was built explicitly to close that gap. It integrates embedding representations derived from three very different kinds of biological data—DNA sequences, amino acid sequences, and protein structures—with the ability to receive and answer natural language queries. In other words, the model holds the molecular alphabet and the human dictionary in the same computational mind.

The engineering behind that fusion is substantial. The researchers fine-tuned Genolator on more than 365,000 question-answer pairs, generated using abstracted Gene Ontology terms. This training corpus teaches the model to respond to queries spanning three core categories of protein function: subcellular localization, meaning where in the cell a protein is found; molecular function, meaning the specific biochemical activity it carries out; and biological processes, meaning the larger cellular programs it contributes to. By abstracting the Gene Ontology terms, the team could turn the structured, hierarchical vocabulary of functional genomics into the kind of question-answer dialogue that language models learn best from.

How well does it work? The evaluation results reported in the study show that Genolator achieves high accuracy in confirming or denying associations between proteins and functions—the fundamental yes-or-no question at the heart of functional annotation. Crucially, the model was benchmarked against serious competition. It outperformed openly available general-purpose large language models such as GPT 4.1, demonstrating that general AI fluency in English does not automatically translate into biological fluency. It also outperformed smaller domain-specific models that incorporate knowledge from a protein structure transformer, indicating that the multimodal integration itself, rather than sheer scale, is what delivers the advantage.

Perhaps the most intriguing part of the study is what the researchers found when they looked inside the model. By examining the hidden states—the internal representational layers that language models build as they process input—the team uncovered an organization that is both biologically and linguistically plausible. That finding matters because a common criticism of large language models in science is that they act as inscrutable black boxes, producing answers without any interpretable internal logic. If Genolator’s learned representations mirror meaningful biological and linguistic structure, it suggests the model is not merely memorizing training pairs but is organizing its knowledge in ways that reflect real relationships among proteins, functions, and the words used to describe them.

The Aachen group went further, dissecting the attention heads—the components of the underlying language model that decide which parts of the input to focus on—and conducting an ablation study, in which parts of the system are systematically removed to test their contribution. Both lines of analysis provided evidence for a genuine benefit of the multimodal approach. Removing or ignoring the genomic and structural inputs diminished performance, supporting the argument that fusing sequence data, structural data, and language is not a gimmick but the source of the model’s power. For a field still debating whether multimodal biology models justify their complexity, this is a meaningful data point.

The practical implications reach into the clinic. The study’s authors are affiliated with the Center for Human Genetics and Genomic Medicine at Uniklinik RWTH Aachen, and the work was funded in part by the START Program and the Clinician Scientist program of the university’s Faculty of Medicine. That institutional context hints at the intended use case: helping clinicians and researchers interpret genetic variants and uncharacterized proteins encountered in patient genomes. When a diagnostician encounters a gene of unknown function in a patient with an unexplained condition, a tool that can rapidly and accurately answer natural-language questions about that gene’s protein product could accelerate the path from raw sequence to mechanistic insight—and, ultimately, to targeted treatment.

It is worth being precise about what Genolator does and does not claim. The model answers queries about protein subcellular localization, molecular function, and biological processes, and its evaluated strength lies in confirming or denying protein-function associations. It is a step toward bridging genomic code and human language, as the authors conclude, rather than a finished oracle of the genome. The training data was generated from Gene Ontology terms, so the model’s competence is bounded by the scope of that vocabulary and the proteins represented within it. And like all language models, its judgments would need to inform, not replace, experimental validation. Still, the direction of travel is clear: a tool that lets biologists converse with molecular data in their own language, rather than forcing every question through specialized computational pipelines.

The open-access publication in Genome Biology, with a peer-review process led by Casey Greene and Tim Sands, means the full study, including supplementary analyses such as t-SNE visualizations of the model’s internal representations, cosine distance heatmaps, and a small case study utilizing GPT 4.1, is freely available for scrutiny and reuse. The research was made possible in part by a cloud environment established in collaboration with the IT Department at Uniklinik RWTH Aachen, and the published version carries a Creative Commons Attribution 4.0 license. As artificial intelligence and genomics continue to converge, Genolator stands as a template for what that convergence might look like: not a machine that replaces biologists, but one that finally speaks their language and the genome’s at the same time. If the multimodal approach holds up as larger models and richer datasets arrive, the monumental task of decoding genetic functionality may become less monumental—and far more conversational—than it has ever been.

Subject of Research: A multimodal large language model for protein function prediction and genomic interpretation

Article Title: Genolator enables protein function interpretation using a multimodal large language model fusing genomic and structural interpretation with natural language interaction

Article References: Danner, M., Islam, T., Begemann, M., Kraft, F., Elbracht, M., Kurth, I., & Krause, J. (2026). Genolator enables protein function interpretation using a multimodal large language model fusing genomic and structural interpretation with natural language interaction. Genome Biology, 27(1), Article 290. https://doi.org/10.1186/s13059-026-04274-w

Image Credits: AI Generated

DOI: 10.1186/s13059-026-04274-w

Keywords: Genolator, large language models, protein function prediction, Gene Ontology, genomics, multimodal AI, protein structure, functional annotation, genome informatics, natural language processing, computational biology, Genome Biology

Microbial bioremediation, the use of naturally occurring microorganisms to degrade contaminants, is widely regarded as one of the most promising and sustainable strategies for BTEX removal. But designing effective bioremediation strategies requires knowing precisely which genes and pathways are present at a contaminated site, and—crucially—which specific BTEX compounds the resident microbes are equipped to degrade. That is far harder than it sounds. The enzymes that initiate BTEX degradation belong to large protein families in which closely related members can target strikingly different substrates. Generic functional annotation pipelines, which assign genes to broad families based on sequence similarity, often cannot tell these near-identical enzymes apart. The result is annotation noise: environmental surveys that detect ‘a degradation gene’ but cannot say whether it acts on benzene, toluene, or neither.

A team of researchers at Carnegie Mellon University, working with a bioinformatics specialist in Pittsburgh, has now built a tool designed to close this gap. The software, called BTEXgenie, is described in a peer-reviewed study published in BMC Genomics. Led by June Qu and Catherine R. Armbruster of Carnegie Mellon’s Department of Biological Sciences, together with Arkadiy I. Garber of Middle Author Bioinformatics, the project set out to create an annotation resource with substrate-specific resolution: one that can distinguish between closely related BTEX-degrading enzymes with different catalytic specificities rather than lumping them into vague functional categories.

The technical heart of BTEXgenie lies in profile hidden Markov models, or HMMs—a statistical framework that has become the workhorse of modern protein annotation. Unlike simple pairwise sequence comparison, a profile HMM captures the consensus of an entire protein family, recording which positions in a multiple sequence alignment are conserved, which tolerate substitutions, and where insertions and deletions commonly occur. This makes HMMs exquisitely sensitive to distant but genuine family members. What sets BTEXgenie apart is the curation of its models: rather than relying on broad, automatically generated family definitions, the team built custom HMMs from alignments of experimentally validated BTEX degradation proteins, anchoring every model to enzymes whose substrates and activities have been confirmed in the laboratory.

That curation pays off dramatically in benchmarking. When the researchers tested BTEXgenie against the widely used KEGG KOfam HMM database across genes involved in BTEX degradation pathways, the new tool achieved an overall sensitivity of 84.36 percent, compared with just 40.74 percent for KOfam—an improvement of 43.62 percentage points. Sensitivity, in this context, measures how many true degradation genes a method successfully recovers. Notably, the gain did not come at the cost of accuracy: BTEXgenie maintained a specificity of 92.28 percent, only marginally below KOfam’s 93.63 percent. In practical terms, BTEXgenie found nearly twice as many genuine degradation genes while producing a comparable rate of false positives—a combination that until now has been difficult to achieve with general-purpose annotation resources.

One of the most significant findings concerns anaerobic BTEX degradation. While the aerobic breakdown of aromatic hydrocarbons is comparatively well characterized, many BTEX-contaminated sites are oxygen-limited, and anaerobic degradation—driven by nitrate-, sulfate-, iron- or methane-cycling microbes—is where much of the real-world remediation action happens. The genes underpinning these anaerobic pathways, including the remarkable fumarate addition enzymes that activate benzene without oxygen, are poorly represented in standard databases. BTEXgenie improved the detection of anaerobic BTEX degradation genes that were entirely absent from KOfam annotations, opening a window onto microbial processes that conventional pipelines simply miss.

To validate the tool beyond benchmarks, the team applied it to real environmental metagenomes—the collective genetic material sequenced directly from contaminated and uncontaminated sites. BTEXgenie recovered pathway patterns that matched reported site characteristics and known degradation potential, suggesting the tool can deliver biologically meaningful pictures of in situ microbial capability rather than laboratory-only performance. For researchers studying polluted aquifers, petroleum reservoirs or marine seeps, this means a metagenomic dataset can now be interrogated not just for ‘hydrocarbon genes’ in the abstract, but for the specific aerobic and anaerobic routes by which benzene, toluene, ethylbenzene and xylene might be dismantled in that environment.

The developers also paid close attention to usability, an often-neglected dimension of bioinformatics software. Beyond raw gene annotation, BTEXgenie supports downstream interpretation through built-in visualization modules: KEGG pathway-based displays map detected functions onto canonical degradation routes, making it easy to see which steps of a pathway are complete and which are missing, while Circos-based visualizations show the genomic distribution of hits across genomes. The tool was refined through user testing, and its documentation walks researchers through annotation and interpretation without requiring deep programming expertise. Supplementary materials released with the paper include detailed tables of the enzyme units used to build the models, their mappings to KEGG Orthology identifiers, Pfam domains and eggNOG or COG annotations, and comparisons with existing hydrocarbon-annotation resources such as CANT-HYD, HADEG and AromaDeg.

The validation framework itself is a model of rigor. The team compiled a reference set of 65 genomes from organisms with experimentally validated BTEX degradation capabilities and documented the presence, absence, or unknown status of each BTEXgenie model—and of 15 well-characterized BTEX-associated enzymes—across that panel. This ground-truthing exercise distinguishes BTEXgenie from tools built purely on computational inference, because every substrate-specific claim traces back to enzymes whose behavior has been measured. It also provides a template for how future substrate-specific annotation resources might be constructed for other pollutant classes, from chlorinated solvents to plastics.

The broader significance of the work extends beyond BTEX itself. As DNA sequencing becomes cheaper, environmental metagenomics is generating an overwhelming torrent of data from contaminated sites worldwide, and the bottleneck has shifted from data collection to interpretation. Tools that embed expert curation and experimental validation into automated annotation pipelines offer a path through that flood, converting raw sequence into actionable ecological and engineering insight. For bioremediation practitioners, BTEXgenie could help identify sites where monitored natural attenuation is feasible, guide the design of bioaugmentation or biostimulation strategies, and track whether degradation potential changes as remediation proceeds. For microbial ecologists, it offers a sharper lens on one of nature’s most consequential metabolic capabilities: the capacity of microorganisms to dismantle the hydrocarbons that humans have scattered across the biosphere. The study, supported by a grant from the Richard King Mellon Foundation and published open access, makes the tool freely available to the research community, and its developers hope it will become a standard component of the environmental genomics toolbox.

Subject of Research: Development of a curated profile HMM-based tool for substrate-specific annotation of microbial BTEX degradation genes

Article Title: BTEXgenie: a curated and user-friendly tool for profile HMM-based substrate-specific annotation of BTEX degradation genes

Article References: Qu, J., Garber, A. I., & Armbruster, C. R. (2026). BTEXgenie: a curated and user-friendly tool for profile HMM-based substrate-specific annotation of BTEX degradation genes. BMC Genomics. https://doi.org/10.1186/s12864-026-13297-3

Image Credits: AI Generated

DOI: 10.1186/s12864-026-13297-3

Keywords: BTEX, bioremediation, hidden Markov models, functional annotation, metagenomics, environmental microbiology, BTEXgenie, hydrocarbon degradation, anaerobic degradation, genomics, pollution, microbial ecology